22nd Century Group Inc. announced Tuesday its board of directors is “evaluating strategic alternatives” for its very-low-nicotine products that at least two analysts say could be a foreshadowing of a ...

Welcome to 22nd Century Group's First Quarter 2025 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode. It is now my pleasure to turn the floor over to ...

22nd Century Group Inc., which is struggling with a dire financial crunch entering 2024, said Thursday it has completed the sale of its hemp/cannabis business. 22nd Century, based in Buffalo, has its ...

22nd Century Group reported a 50% sequential sales increase, advancing its 2025 growth strategy with new product launches and partnerships. 22nd Century Group, Inc. announced a 50% sequential increase ...

22nd Century Group (XXII) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has launched a new ...

22nd Century Group, Inc. misses on earnings expectations. Reported EPS is $-1.89 EPS, expectations were $-1.1. Operator: Welcome to 22nd Century Group’s First Quarter 2025 Conference Call and Webcast.

22nd Century Group, Inc. beats earnings expectations. Reported EPS is $-48.96, expectations were $-648. Operator: Welcome to 22nd Century Group’s Fourth Quarter and Full Year 2024 Conference Call and ...

Welcome to 22nd Century Group's Third Quarter 2025 Conference Call and Webcast. [Operator Instructions] It is now my pleasure to turn the floor over to Matt Kreps, Investor Relations for 22nd Century ...